Pfizer to end license deal with Syros for blood disorder therapies

(Reuters) - Syros Pharmaceuticals said on Friday Pfizer will terminate a license deal between the companies related to the development of novel therap...

Related Keywords

Bengaluru ,Karnataka ,India ,Shailesh Kuber ,Savyata Mishra ,Sriparna Roy ,Pfizer ,Reuters ,Syros Pharmaceuticals ,Friday Pfizer ,Global Blood Therapeutics , ,